Arrowhead Pharmaceuticals Inc (ARWR) — Long-term Investment Intensity
Arrowhead Pharmaceuticals Inc (ARWR) has a Long-term Investment Intensity of 5.4% as of June 2023. Long-term investments of $42.76 Million represent 5.4% of total assets of $795.86 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Arrowhead Pharmaceuticals Inc asset resilience ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Arrowhead Pharmaceuticals Inc Long-term Investment Intensity (2014–2023)
This chart shows how Arrowhead Pharmaceuticals Inc's Long-term Investment Intensity has evolved across 6 annual periods from 2014 to 2023. As of June 2023, the intensity stands at 5.4%, reflecting long-term investments of $42.76 Million against total assets of $795.86 Million USD. For the complete balance sheet picture, see ARWR total assets.
Annual Long-term Investment Intensity for Arrowhead Pharmaceuticals Inc (2014–2023)
The table below presents the year-by-year Long-term Investment Intensity for Arrowhead Pharmaceuticals Inc from 2014 to 2023, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Arrowhead Pharmaceuticals Inc total liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2023 | 38.2% | $292.74 Million | $765.55 Million | ▲ +22.9 pp |
| 2022 | 15.3% | $105.87 Million | $691.94 Million | ▼ -19.3 pp |
| 2021 | 34.6% | $245.59 Million | $710.15 Million | ▲ +8.3 pp |
| 2020 | 26.3% | $137.49 Million | $522.50 Million | ▲ +13.7 pp |
| 2019 | 12.6% | $44.18 Million | $349.85 Million | ▼ 0.0 pp |
| 2014 | 12.6% | $23.09 Million | $182.82 Million | — |